Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis

Smith Giri, MBBS, Peter Barth, MD, Luciano J. Costa, MD PhD, Adam J Olszewski, MD

Blood (2019) 134 (Supplement_1): 1862.

https://doi.org/10.1182/blood-2019-131231

Published: 2019

Journal Articles

Retrospective EHR Study on Effectiveness of Eltrombopag in Cancer Treatment-Related Thrombocytopenia

Anjali Pawar, MD, Vamsidhar Velcheti, MD, Lincy S. Lal, Lisa Le, Katherine Andrade, Isha Desai, Pallavi Patwardhan, PhD

Blood (2019) 134 (Supplement_1): 1100.

https://doi.org/10.1182/blood-2019-124781

Published: 2019

Journal Articles

Incidence and Outcomes Associated with Distal Deep Vein Thrombosis in 760,344 Patients with 13 Common Malignancies

Richard H White, MD, Ann M Brunson, MS, Anjlee Mahajan, MD, Theresa H.M. Keegan, PhD MS, Ted Wun, MD

Blood (2018) 132 (Supplement 1): 2526.

https://doi.org/10.1182/blood-2018-99-110872

Published: 2018

Journal Articles

The Hypomorphic Gata1 low Mutation Induces Fibrosis in Multiple Organs

Maria Zingariello, Laura Sancillo, Fabrizio Martelli, Paola Verachi, Claudio Bardelli, Mauro Valeri, Yujin Hoshida, Fiorella Ciaffoni, Manuela Marra, Rosa Alba Rana, Anna Rita Migliaccio, PhD

Blood (2018) 132 (Supplement 1): 3059.

https://doi.org/10.1182/blood-2018-99-110927

Published: 2018

Journal Articles

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

Daniel Teschner, MD, Anna Cholaszczyńska, Frederic Ries, Hendrik Beckert, Matthias Theobald, Stephan Grabbe, MD, Markus P. Radsak, MD, Matthias Bros, PhD

Blood (2018) 132 (Supplement 1): 3690.

https://doi.org/10.1182/blood-2018-99-111843

Published: 2018

Journal Articles

No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)

Lilian Iglesias, Sudipto Mukherjee, MD PhD MPH, Aziz Nazha, MD, Anjali S. Advani, MD, Aaron T. Gerds, MDMS, Hetty E. Carraway, MD MBA, Matt Kalaycio, MD, Jaroslaw P. Maciejewski, PhD MD FACP, Navneet S. Majhail, MD MS, Mikkael A. Sekeres, MD MS

Blood (2017) 130 (Supplement 1): 2872.

https://doi.org/10.1182/blood.V130.Suppl_1.2872.2872

Published: 2017

Journal Articles

High Risk of Infections in Chronic Lymphocytic Leukemia Patients Treated with B-Cell Receptor Inhibitors

Annalynn M Williams, MS, Andrea M Baran, MS, Philip J Meacham, MS, Megan Herr, BS, Hugo E. Valencia, MD, Catherine Newsom, Nealansh Gupta, Michelle Janelsins, PhD, Paul M. Barr, Clive S Zent, MD

Blood (2016) 128 (22): 3203.

https://doi.org/10.1182/blood.V128.22.3203.3203

Published: 2016

Journal Articles

First-in-Man Emergency Use of Plasminogen Replacement for Respiratory Failure Due to Congenital Hypoplasminogenemia

Wolf A Hassenpflug, MD, John Moran, MD, Johanna Schrum, MD, Sarah Müller-Stöver, MD, Sonja Schneppenheim, MD, Reinhard Schneppenheim

Blood (2016) 128 (22): 3792.

https://doi.org/10.1182/blood.V128.22.3792.3792

Published: 2016

Journal Articles

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Kathan Dilipbhai Mehta, MBBS, MPH, Leonard Appleman, MDPhD, Hong Wang, PhD, Roy E. Smith, MD, Rahul Atul Parikh, MD PhD

Blood (2015) 126 (23): 2060.

https://doi.org/10.1182/blood.V126.23.2060.2060

Published: 2015

Journal Articles

Invasive Fusariosis in Patients with Hematologic Malignancies at a University Hospital

Vildan Ozkocaman, Associated Professor, Fahir Ozkalemkas, Professor, Burcu Dalyan Cilo, expert doctor, Tugcan Alp, expert doctor, Tuba Ersal, expert doctor, Erdem Gozden, expert doctor, Zafer Serenli Yegen, expert doctor, Ali Ridvan, Professor, Beyza Ener, Professor

Blood (2015) 126 (23): 4906.

https://doi.org/10.1182/blood.V126.23.4906.4906

Published: 2015

Journal Articles

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Robert M. Rifkin, MD, Rafat Abonour, MD, Jatin J. Shah, MD, Jayesh Mehta, MD, Mohit Narang, MD, Howard R. Terebelo, DO, Cristina J Gasparetto, MD, Sachdev P. Thomas, MD, Kathleen Toomey, MD, James W Hardin, PhD, Jane Jie Lu, MS, Laurie Kenvin, BSN, RN, Shankar Srinivasan, PhD, Rosanna J. Ricafort, MD, Yasir Nagarwala, MD, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4749.

https://doi.org/10.1182/blood.V124.21.4749.4749

Published: 2014

Journal Articles

Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival

Iris Bigalke, MD, Kirsti Honnashagen, Marianne Lundby, Julitta Kasten, Else Marit Suso Inderberg, PhD, Lisbeth Skoge, Stein Saboe-Larssen, PhD, Dolores J Schendel, PhD, Gunnar Kvalheim, MD PhD

Blood (2014) 124 (21): 2440.

https://doi.org/10.1182/blood.V124.21.2440.2440

Published: 2014

Journal Articles

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma

Ayed O Ayed, MD, Jan S Moreb, MD, Jack W. Hsu, MD, John W Hiemenz, MD, John R Wingard, MD, Maxim Norkin, MD PhD

Blood (2014) 124 (21): 5761.

https://doi.org/10.1182/blood.V124.21.5761.5761

Published: 2014

Journal Articles

Platelet Pitpa Is Not Essential for Hemostasis, but Is Required for Tumor Metastasis Formation

Liang Zhao, PhD, Aae Suzuki, Timothy J. Stalker, PhD, Lurong Lian, MD, Min Sang, MD, Amy C Durham, VMD, Charles S. Abrams, MD

Blood (2014) 124 (21): 342.

https://doi.org/10.1182/blood.V124.21.342.342

Published: 2014

Journal Articles

Second Cancer Incidence Among Chronic Lymphocytic Leukemia (CLL) Patients: A French Population-Based Study

Edouard Cornet, Jérémie Jégu, Morgane Mounier, Marc Maynadié, Alain Monnereau, MD PhD, Michel Velten, Xavier Troussard, MD PhD

Blood (2014) 124 (21): 3303.

https://doi.org/10.1182/blood.V124.21.3303.3303

Published: 2014

Journal Articles

Second Primary Malignancies In Adult Acute Lymphoblastic Leukemia

Binay K. Shah, MD, Krishna B Ghimire, MD

Blood (2013) 122 (21): 3871.

https://doi.org/10.1182/blood.V122.21.3871.3871

Published: 2013

Journal Articles

First Description Of a t(10;11)(q22;q23)/ MLL-TET1 Reciprocal Translocation In a T Lymphoblastic Lymphoma With Subsequent Lineage Switch To Acute Myelomonocytic Myeloid Leukemia

Antoine Ittel, Eric Jeandidier, MD, Nathalie Perrusson, Catherine Humbrecht, Bruno Lioure, MD, Isabelle Mazurier, Caroline Mayeur-Rousse, Carine Gervais, MD, Catherine Helias, Sylvie Thiebault, MD, Felix Lerintiu, Laurent Mauvieux, MD, PhD

Blood (2013) 122 (21): 1357.

https://doi.org/10.1182/blood.V122.21.1357.1357

Published: 2013

Journal Articles

Prognostic Value of Positron Emission Tomography- Computed Tomography in Patients with Marginal Zone Lymphoma

Ji Hyun Park, MD, Dok Hyun Yoon, MD, Sun Mok Kim, Jae-Cheol Jo, Jeongseok Kim, MD, Shin Kim, RN, Kyoungmin Lee, RN, Eun Hee Kang, RN, Sang-wook Lee, MD, Chan-Sik Park, MD, Jooryung Huh, Cheolwon Suh, MD

Blood (2012) 120 (21): 5084.

https://doi.org/10.1182/blood.V120.21.5084.5084

Published: 2012

Journal Articles

Variable Risk of Second Primary Malignancy In Multiple Myeloma Patients of Different Ethnicities

Pedram Razavi, MD, PhD, Gaurav Patel, MSHA, Asher Chanan-Khan, MD, Sikander Ailawadhi, MD

Blood (2011) 118 (21): 678.

https://doi.org/10.1182/blood.V118.21.678.678

Published: 2011

Journal Articles

Second Malignancies Among Elderly Multiple Myeloma Patients Exposed to Bortezomib and Other Treatments: An Analysis of the US SEER-Medicare Linked Database,

Dina Gifkins, PhD, Megan McAuliffe, ScD, Amy Matcho, BS, Jane Porter, MS, Scott Chavers, PhD, Maria Ponsillo, MD, Jay King, MD, Avinash Desai, MD, Andrew Cakana, MD, Dixie-Lee Esseltine, MD

Blood (2011) 118 (21): 3972.

https://doi.org/10.1182/blood.V118.21.3972.3972

Published: 2011

NARROW

Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis

Retrospective EHR Study on Effectiveness of Eltrombopag in Cancer Treatment-Related Thrombocytopenia

Incidence and Outcomes Associated with Distal Deep Vein Thrombosis in 760,344 Patients with 13 Common Malignancies

The Hypomorphic Gata1 low Mutation Induces Fibrosis in Multiple Organs

CD11b Regulates Fungal Outgrowth but Not Neutrophil Recruitment in a Mouse Model of Invasive Pulmonary Aspergillosis

No Excess Risk of Second Malignancies in Chronic Myeloid Leukemia (CML) Patients Treated with Tyrosine Kinase Inhibitors (TKIs)

High Risk of Infections in Chronic Lymphocytic Leukemia Patients Treated with B-Cell Receptor Inhibitors

First-in-Man Emergency Use of Plasminogen Replacement for Respiratory Failure Due to Congenital Hypoplasminogenemia

National Epidemiology of Venous Thromboembolism in Patients with Malignancy in United States from 1993 to 2012

Invasive Fusariosis in Patients with Hematologic Malignancies at a University Hospital

Connect MM®—the Multiple Myeloma (MM) Disease Registry: Incidence of Second Primary Malignancies (SPM)

Vaccination with a New Generation of Fast Dendritic Cells Transfected with mRNA from hTERT, Survivin and Autologous Tumor Mount Strong Immune Responses and Prolong Survival

Severe Diffuse Alveolar Hemorrhage Associated with Bortezomib Administration in Patients with Multiple Myeloma

Platelet Pitpa Is Not Essential for Hemostasis, but Is Required for Tumor Metastasis Formation

Second Cancer Incidence Among Chronic Lymphocytic Leukemia (CLL) Patients: A French Population-Based Study

Second Primary Malignancies In Adult Acute Lymphoblastic Leukemia

First Description Of a t(10;11)(q22;q23)/ MLL-TET1 Reciprocal Translocation In a T Lymphoblastic Lymphoma With Subsequent Lineage Switch To Acute Myelomonocytic Myeloid Leukemia

Prognostic Value of Positron Emission Tomography- Computed Tomography in Patients with Marginal Zone Lymphoma

Variable Risk of Second Primary Malignancy In Multiple Myeloma Patients of Different Ethnicities

Second Malignancies Among Elderly Multiple Myeloma Patients Exposed to Bortezomib and Other Treatments: An Analysis of the US SEER-Medicare Linked Database,

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only